Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Has anyone seen/read this article from 2 days ago on MedScape.
Researchers found that the genetic signal is likely to affect cells in the lung. By finely examining DNA at the site of the genetic signal (LZTFL1 gene) controlled by the so-called 'switch', they identified the gene responsible for the greater risk of developing severe COVID-19.
News > Medscape News UK
Gene Identified for High Risk of COVID Mortality Much More Common in South Asians
Becky McCall
November 05, 2021
1
A gene that doubles the risk of respiratory failure and death from COVID-19, and is present in 60% of South Asians, but only 15% of Europeans, has been identified and might explain the excess deaths in some ethnic groups over others.
Researchers from Oxford University led by James Davies, consultant in intensive care medicine and associate professor of genomics, and Jim Hughes, PhD, professor of gene regulation, both at the University of Oxford's MRC Weatherall Institute of Molecular Medicine, used an artificial intelligence algorithm to analyse huge quantities of genetic data from hundreds of types of cells, to show that the gene, leucine zipper transcription factor-like 1 (LZTFL1), is associated with lung function rather than the immune system. The study findings are published in Nature Genetics.
Has anyone seen/read this article from 2 days ago on MedScape.
Researchers found that the genetic signal is likely to affect cells in the lung. By finely examining DNA at the site of the genetic signal (LZTFL1 gene) controlled by the so-called 'switch', they identified the gene responsible for the greater risk of developing severe COVID-19.
News > Medscape News UK
Gene Identified for High Risk of COVID Mortality Much More Common in South Asians
Becky McCall
November 05, 2021
1
A gene that doubles the risk of respiratory failure and death from COVID-19, and is present in 60% of South Asians, but only 15% of Europeans, has been identified and might explain the excess deaths in some ethnic groups over others.
Researchers from Oxford University led by James Davies, consultant in intensive care medicine and associate professor of genomics, and Jim Hughes, PhD, professor of gene regulation, both at the University of Oxford's MRC Weatherall Institute of Molecular Medicine, used an artificial intelligence algorithm to analyse huge quantities of genetic data from hundreds of types of cells, to show that the gene, leucine zipper transcription factor-like 1 (LZTFL1), is associated with lung function rather than the immune system. The study findings are published in Nature Genetics.
Has anyone seen/read this article from 2 days ago on MedScape.
Researchers found that the genetic signal is likely to affect cells in the lung. By finely examining DNA at the site of the genetic signal (LZTFL1 gene) controlled by the so-called 'switch', they identified the gene responsible for the greater risk of developing severe COVID-19.
News > Medscape News UK
Gene Identified for High Risk of COVID Mortality Much More Common in South Asians
Becky McCall
November 05, 2021
1
A gene that doubles the risk of respiratory failure and death from COVID-19, and is present in 60% of South Asians, but only 15% of Europeans, has been identified and might explain the excess deaths in some ethnic groups over others.
Researchers from Oxford University led by James Davies, consultant in intensive care medicine and associate professor of genomics, and Jim Hughes, PhD, professor of gene regulation, both at the University of Oxford's MRC Weatherall Institute of Molecular Medicine, used an artificial intelligence algorithm to analyse huge quantities of genetic data from hundreds of types of cells, to show that the gene, leucine zipper transcription factor-like 1 (LZTFL1), is associated with lung function rather than the immune system. The study findings are published in Nature Genetics.
Moving back up......38's in play
Low volume day
SHORT INTEREST
DATE SHORT INTEREST % CHANGE AVG. DAILY SHARE VOL DAYS TO COVER SPLIT NEW ISSUE
10/15/2021 29,858 -75.91 1,149,552 1 No No
09/30/2021 123,955 295.11 914,173 1 No No
09/15/2021 31,372 -26.94 1,936,275 1 No No
08/31/2021 42,938 200.27 1,138,152 1 No No
08/13/2021 14,300 31.36 4,121,551 1 No No
07/30/2021 10,886 -71.23 1,289,835 1 No No
07/15/2021 37,839 -74.08 2,316,049 1 No No
06/30/2021 145,964 -66.92 1,936,435 1 No No
06/15/2021 441,244 -45.96 1,496,116 1 No No
05/28/2021 816,823 -0.03 1,588,429 1 No No
OTCMarkets.com
SHORT INTEREST UPDATE
DATE SHORT INTEREST % CHANGE AVG. DAILY SHARE VOL DAYS TO COVER SPLIT NEW ISSUE
10/15/2021 29,858 -75.91 1,149,552 1 No No
09/30/2021 123,955 295.11 914,173 1 No No
09/15/2021 31,372 -26.94 1,936,275 1 No No
08/31/2021 42,938 200.27 1,138,152 1 No No
08/13/2021 14,300 31.36 4,121,551 1 No No
07/30/2021 10,886 -71.23 1,289,835 1 No No
07/15/2021 37,839 -74.08 2,316,049 1 No No
06/30/2021 145,964 -66.92 1,936,435 1 No No
06/15/2021 441,244 -45.96 1,496,116 1 No No
05/28/2021 816,823 -0.03 1,588,429 1 No No
1.5mm shares now traded
More than a 1mm plus shares traded so far, up 10%+, and a 6:1 on the BUY
Hopefully a start to RECOVERY.....ready to move back up....
IPIX is currently the #1 Most Read board on IHUB. Lots of eyes....
National Institutes of Health (NIH) Director Dr. Francis Collins confirmed in a public forum that three such drugs from small, innovative biotech companies, Leronlizumab, Lenzilumab, and Aviptadil are among the few viable candidates for treating COVID-19 of the more than 750 compounds screened by the National Institutes of Health. Yet, inexplicably, despite clear early evidence of efficacy Leronlizumab and Lenzilumab have been denied EUA and Aviptadil has been awaiting an EUA decision already for 150 days.
Holding with you Lakota...not much but 550,000.
I just gotta say it….this is bullshit!!
Excited for ipix opportunities! Should be great 2022.
My dumb ass held. Doing quite well with rvvtf but lost most, solid gains in the other. Bought at .03 though so hanging on.
Looks like…
Rvvtf and RLFTF? Me too…
Nice afternoon action
Nice action this morning
Both CDEL and JANE mm on this.....GEEZE!
Nice day today. Great way to start the week!
Pretty pathetic today
What the heck is going on with the stock? Completely petered out!
????
Thanks. Possible limit trades.
Good to know
Could new shares be flooding the market?
Nicely….Would love to hang on to gain
Agree….excellent video and nice forecast.
Well I'll be....we managed to close above .30! Good times!!
Nice! Would be better if we were pr’d accordingly. Spread the gospel so to speak.
Nice movement today.
PW…Thanks fir posting.
He has a lot going forward him
As such, he graduated Summa Cum Laude with a 3.95 GPA and earned a total of six undergraduate degrees before pursuing his medical degree. After graduating medical school, he enrolled in a Master’s program for public health, thus working towards his eighth and final degree.
Repost from @yahoo David Triplett
FWIW
Artificial Intelligence Technology Solutions Stock Forecast, "AITX" Share Price
Prediction Charts
Is "Artificial Intelligence Technology Solutions Inc" a Good Investment? Current price today: ?0.04040 USD (-0.247%)
“Should I invest in Artificial Intelligence Technology Solutions stock?" "Should I trade "AITX" stock today?" According to our live Forecast System, Artificial Intelligence Technology Solutions Inc stock is an awesome long-term (1-year) investment*. "AITX" stock predictions are updated every 5 minutes with latest exchange prices by smart technical market analysis. Q&A about "AITX" projections.
At Walletinvestor.com we predict future values with technical analysis for wide selection of stocks like Artificial Intelligence Technology Solutions Inc (AITX). If you are looking for stocks with good return, Artificial Intelligence Technology Solutions Inc can be a profitable investment option. Artificial Intelligence Technology Solutions Inc quote is equal to 0.04040 USD at 2021-10-27. Based on our forecasts, a long-term increase is expected, the "AITX" stock price prognosis for 2026-10-23 is 7.464 USD. With a 5-year investment, the revenue is expected to be around +18375.35%. Your current $100 investment may be up to $18475.35 in 2026.
Note: due to the specific nature of Artificial Intelligence Technology Solutions stock, the prediction can be significantly excessive / unrealistic!
Strongest takeaway
At visit 4, 5 and 6, a trend in favor of the 3 times a day treated group vs. control group was observed (10% of patients using Sentinox tested negative at V4 vs 0% of patients in the control arm; 40% of patients using Sentinox tested negative vs 20% in the control arm at V5; 70% of patients using Sentinox tested negative vs 40% at V6). For the purpose of this study, subjects are considered negative when their COVID-19 test becomes negative and remains negative throughout the study period.